Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05440448 · ClinicalTrials.gov registry record · NA

Patch-free Occlusion Therapy

A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT05440448 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 68 participants, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05440448, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.

Conditions Studied

Interventions

  • DEVICE Patch-free occlusion therapy
  • DEVICE Adhesive patch

Study Locations (1)

Texas

  • Retina Foundation - Dallas

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-04-22
Est. Completion 2028-06-30
Phase NA

Sponsor

Retina Foundation of the Southwest

11 total trials

What the Registry Record Tells You About NCT05440448

The ClinicalTrials.gov registry entry for NCT05440448 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 24 other Amblyopia trials with a reported enrollment target (58% lower). The listed sponsor is Retina Foundation of the Southwest, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Patch-free occlusion therapy is the first listed.

NCT05440448 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05440448 about?

NCT05440448 is a clinical study titled "Patch-free Occlusion Therapy". The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.

What is the current status of trial NCT05440448?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-04-22. Estimated completion is 2028-06-30.

What conditions does trial NCT05440448 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT05440448?

The interventions under investigation include: Patch-free occlusion therapy (DEVICE), Adhesive patch (DEVICE).

Who is sponsoring clinical trial NCT05440448?

This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05440448 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.